- Home
- ZLAB vs HSAI Comparison
ZLAB vs HSAI Comparison
Compare ZLAB & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- HSAI
- Stock Information
- Founded
- ZLAB 2013
- HSAI 2014
- Country
- ZLAB China
- HSAI China
- Employees
- ZLAB N/A
- HSAI N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- HSAI
- Sector
- ZLAB Health Care
- HSAI
- Exchange
- ZLAB Nasdaq
- HSAI Nasdaq
- Market Cap
- ZLAB 3.2B
- HSAI 3.1B
- IPO Year
- ZLAB 2017
- HSAI 2023
- Fundamental
- Price
- ZLAB $20.98
- HSAI $18.29
- Analyst Decision
- ZLAB Buy
- HSAI Strong Buy
- Analyst Count
- ZLAB 6
- HSAI 4
- Target Price
- ZLAB $57.22
- HSAI $31.58
- AVG Volume (30 Days)
- ZLAB 899.6K
- HSAI 2.7M
- Earning Date
- ZLAB 11-06-2025
- HSAI 11-11-2025
- Dividend Yield
- ZLAB N/A
- HSAI N/A
- EPS Growth
- ZLAB N/A
- HSAI N/A
- EPS
- ZLAB N/A
- HSAI 0.44
- Revenue
- ZLAB $441,629,000.00
- HSAI $385,835,909.00
- Revenue This Year
- ZLAB $40.71
- HSAI $61.81
- Revenue Next Year
- ZLAB $50.42
- HSAI $45.58
- P/E Ratio
- ZLAB N/A
- HSAI $44.77
- Revenue Growth
- ZLAB 24.14
- HSAI 43.17
- 52 Week Low
- ZLAB $20.61
- HSAI $4.10
- 52 Week High
- ZLAB $44.34
- HSAI $30.85
- Technical
- Relative Strength Index (RSI)
- ZLAB 21.54
- HSAI 31.95
- Support Level
- ZLAB $21.59
- HSAI $20.25
- Resistance Level
- ZLAB $22.28
- HSAI $24.25
- Average True Range (ATR)
- ZLAB 0.86
- HSAI 1.35
- MACD
- ZLAB -0.18
- HSAI -0.32
- Stochastic Oscillator
- ZLAB 6.41
- HSAI 3.70
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About HSAI Hesai Group each ADS represents one Class B ordinary share
Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.